Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Validation of Nutritrauma strategy for detection of harmful effects of medical nutritional treatment in critically ill patients in real life

Version 1 : Received: 15 June 2023 / Approved: 16 June 2023 / Online: 16 June 2023 (12:10:10 CEST)

How to cite: Parisi, J.; Martínez de Lagran, I.; Serra-Prat, M.; Roca, M.; Merino, R.; De la Torre, M.D.C.; Campins, L.; Yébenes, J.C. Validation of Nutritrauma strategy for detection of harmful effects of medical nutritional treatment in critically ill patients in real life. Preprints 2023, 2023061237. https://doi.org/10.20944/preprints202306.1237.v1 Parisi, J.; Martínez de Lagran, I.; Serra-Prat, M.; Roca, M.; Merino, R.; De la Torre, M.D.C.; Campins, L.; Yébenes, J.C. Validation of Nutritrauma strategy for detection of harmful effects of medical nutritional treatment in critically ill patients in real life. Preprints 2023, 2023061237. https://doi.org/10.20944/preprints202306.1237.v1

Abstract

Aims: Medical Nutritional Treatment (MNT) can be complex and associated to potential meta-bolic complications, which has been recently described as Nutritrauma. There is no data on the effect of applying this strategy in clinical practice. The aim of our work is to describe if applica-tion of Nutritrauma concept in real live is useful to detect metabolic complications associated to the prescription of MNT in critically ill patients. Methods: In this descriptive prospective study at a single center, we enrolled 30 consecutive crit-ical ill patients of a 14 beds medical – surgical Intensive Care Unit. The Nutritrauma strategy implementation was based in four M steps: Metabolic screening, MNT prescription, Biochemical Monitoring and Nutritional Management. The primary endpoint was to describe the metabolic complications of the MNT detected with Nutritrauma strategy. Secondary endpoint was to de-scribe the most frequent causes of inappropriate prescription. Results: We analysed 28 patients (mean age 69,7 ± 11,3 years; APACHE II 18,1 ± 8,1, SOFA 7,5 ± 3,7; Nutric Score modified 4,3 ± 2,01 and mean BMI 27,2 ± 3,8). The most frequent disease on admission was sepsis (46,4%). Length of ICU stay was 20,6 ± 15,1 days and 39,3% died during the ICU stay. Enteral nutrition (82,1%) was more frequent than parenteral nutrition (17,9%). During nutritional monitoring 54 specific analytical determinations were made. Hyperglycemia was the most frequent metabolic alteration (83,3% of the determinations). Electrolyte disturbance were hypocalcemia (50%), hypophosphatemia (29,6%) and hypokalemia (27,8%). The most frequent lipid profile abnormality were hypocholesterolemia (64,8%) and hypertriglyceridemia (27,8%). Furthermore, nutritional prescription was modified in the 53,6% of patients: increase protein dosage (25%), increase caloric dosage (21,4%) and change to an organ-specific diet (17,8%). Conclusions: The application of Nutritrauma strategy facilitate the detection of metabolic com-plications and the evaluation of the appropiate prescription of the MNT.

Keywords

Metabolic complications; critically ill; nutritrauma; medical nutrition therapy; enteral nutrition; parenteral nutrition.

Subject

Medicine and Pharmacology, Dietetics and Nutrition

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.